Comparative Effects of Acetate- and Citrate-Based Dialysates on Dialysis Dose and Protein-Bound Uremic Toxins in Hemodiafiltration Patients: Exploring the Impact of Calcium and Magnesium Concentrations

• Published in: Toxins 2024-10, Vol.16 (10), p.426
• Main Authors: Rodríguez-Espinosa, Diana, Cuadrado-Payán, Elena, Rico, Naira, Torra, Mercè, Fernández, Rosa María, Gómez, Miquel, Morantes, Laura, Casals, Gregori, Rodriguez-Garcia, Maria, Maduell, Francisco, Broseta, José Jesús
• Format: Article
• Language: English
• Subjects: acetate; Acetates; Acetic acid; Adult; Aged; Albumin; Albumins; Anticoagulants; Bicarbonates; Binding sites; Calcium; Calcium - blood; Calcium buffering; Calcium sulfate; Calcium, Dietary; citrate; Citric Acid; Comparative analysis; Creatinine; Cresols - blood; Cross-Over Studies; Dialysate; Dialysis; dialysis efficiency; Dialysis Solutions - chemistry; Dialyzers; Efficiency; Female; Health aspects; Hemodiafiltration; Hemodialysis; Humans; Indican - blood; Influence; Kidney diseases; Magnesium; Magnesium - blood; Magnesium in the body; Male; Materials; Measurement; Methods; Middle Aged; Mortality; Oxidative stress; Prospective Studies; Protein Binding; Protein composition; protein-bound toxins; Proteins; Ratios; Statistical analysis; Sulfate reduction; Sulfates; Sulfuric Acid Esters - blood; Toxins; Urea; Urea - blood; Ureas; Uremia - blood; Uremia - therapy; uremic toxins; Uremic Toxins - blood; Variance analysis
• ISSN: 2072-6651; 2072-6651
• DOI: 10.3390/toxins16100426

Modern hemodialysis employs weak acids as buffers to prevent bicarbonate precipitation with calcium or magnesium. Acetate, the most used acid, is linked to chronic inflammation and poor dialysis tolerance. Citrate has emerged as a potential alternative, though its effect on dialysis efficiency is not clear. This study aims to compare the efficacy of acetate- and citrate-based dialysates, focusing on protein-bound uremic toxins and dialysis doses. This single-center prospective crossover study includes prevalent patients participating in a thrice-weekly online hemodiafiltration program. Four dialysates were tested: two acetate-based (1.25 and 1.5 mmol/L calcium) and two citrate-based (1.5 mmol/L calcium with 0.5 and 0.75 mmol/L magnesium). Pre- and post-dialysis blood samples of eighteen patients were analyzed for urea, creatinine, p-cresyl sulfate, indoxyl sulfate, and albumin. Statistical significance was assessed using paired -tests and repeated measures of ANOVA. There were no significant differences in dialysis dose (Kt), urea, creatinine, or indoxyl sulfate reduction ratios between acetate- and citrate-based dialysates. However, a significant decrease in the reduction ratio of p-cresyl sulfate was observed with the acetate dialysate containing 1.25 mmol/L calcium and the citrate dialysate with 0.5 mmol/L magnesium compared to the acetate dialysate containing 1.5 mmol/L calcium and the citrate dialysate with 0.75 mmol/L magnesium (51.56 ± 4.75 and 53.02 ± 4.52 vs. 65.25 ± 3.38 and 58.66 ± 4.16, 0.007). No differences in dialysis dose were found between acetate- and citrate-based dialysates. However, citrate dialysates with lower calcium and magnesium concentrations may reduce the albumin displacement of p-cresyl sulfate. Further studies are needed to understand the observed differences and optimize the dialysate composition for the better clearance of protein-bound uremic toxins.